Category: Finance
-
Q3 Venture Funds Inch Up, Early-Stage Deals Drop
Venture capital funding rose in the third quarter of 2020, driven in large part by investments in already established companies rather than newer enterprises.
-
Lilly Gains Neuro Disease Biotech in $1.36B Deal
Drug maker Eli Lilly and Co. is acquiring Disarm Therapeutics, a biotechnology company developing treatments for neurodegenerative disorders.
-
New Funds Advance Hand-Wrist Neural Rehab Device
Developers of a system to help people with spinal cord injuries regain use of their hands and wrists, are configuring the device for home use.
-
DoD Funding Mobile Vaccine/Therapy Manufacturing Lab
The U.S. Defense Department’s research agency is funding a prototype mobile lab to produce RNA-based vaccines and therapies in the field on demand.
-
New Company IDs Drugs Targeting Cancer Cell Networks
A start-up company is using artificial intelligence to discover drugs that address the tumor stroma, a cellular network supporting cancerous tumors.
-
Microbiome Therapies Company Unveils, Raises $50M
A new enterprise is underway developing therapeutics targeting bacterial communities in the body, to treat metabolic disorders and cancer.
-
Heart Disease Biotech Acquired in $13.1B Deal
A company developing precision medicine drugs to treat inherited heart disorders was acquired by drug maker Bristol Myers Squibb, or BMS, for $13.1 billion.
-
BARDA Funding Vaccine Patch Clinical Trial
The U.S. government’s medical preparedness agency is funding a clinical trial of a patch that dispenses vaccines with a much lower dose than syringes.
-
Infographic – Global Climate Technology Hubs
The report also highlights where the investments were made, with the geographic hubs or clusters attracting the most investments, this weekend’s infographic.
-
Group Advancing Electronic Spinal Cord Injury Therapies
A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries.